Journal profile · Biochemical Research Methods
New Biotechnology
ISSN 1871-6784 · eISSN 1876-4347 · Elsevier · NETHERLANDS · Bimonthly · Founded 2008
New Biotechnology: CAS Zone 2 · Biology (2025 upgraded edition); impact factor 5.65; fully open access; APC about USD 3,180; median 96 days to acceptance (101 articles, last 24 months); community-reported acceptance: fairly easy (Elsevier website: 35%); 561 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
New Biotechnology is published by Elsevier and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Microbial Metabolic Engineering and Bioproduction, Biofuel production and bioconversion and Enzyme Catalysis and Immobilization, together about 36.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
New Biotechnology is an official journal of the European Federation of Biotechnology (EFB) and the Asian Federation of Biotechnology (AFOB). A bimonthly publication, it covers both the science of biotechnology and its surrounding business and financial milieu. The journal publishes peer-reviewed basic research papers, authoritative reviews, feature articles, and opinions in all areas of biotechnology. It reflects the full diversity of current biotechnology science, particularly those advances in research and practice that offer opportunities for exploitation of knowledge, commercially or otherwise, together with discussion and comment on broader issues of general interest and concern. The outlook is fully international.The scope of the journal includes the research, industrial, and commercial aspects of biotechnology, in areas including health care and pharmaceuticals, immunotherapy and diagnostics, biofuels, genetic engineering, genomics, synthetic biology, molecular technologies, environmental biotechnology, bioeconomy, biobased materials, nanotechnology, food and agriculture, biocatalysis, bioremediation, process engineering, bioinformatics and databases, and digital technologies and artificial intelligence, where they relate to biotechnology.
From the journal's Aims & Scope
Research area (LetPub): Biochemical Research Methods
Editor-in-chief Tae Seok MoonPublisher website
Editorial board by country: 5 in mainland China (about 10%); most named United States 15, Germany 6, Mainland China 5, Italy 3, Sweden 3 (49 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology13.9%
- Biofuel production and bioconversionEngineering12.5%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology9.9%
- Enzyme Production and CharacterizationBiochemistry, Genetics and Molecular Biology7%
- Viral Infectious Diseases and Gene Expression in InsectsBiochemistry, Genetics and Molecular Biology5.2%
- Monoclonal and Polyclonal Antibodies ResearchMedicine4.6%
- Algal biology and biofuel productionEnergy4.4%
- biodegradable polymer synthesis and propertiesMaterials Science4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemical Research Methods | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemical Research Methods | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemical Research Methods | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.65LetPub ·
- Impact factor (publisher)
- 5.6Publisher website ·
- CiteScore 2026-06
- 9.2LetPub ·
- CiteScore (publisher)
- 9.2Publisher website ·
- SJR 2026-06
- 1.06LetPub ·
- SNIP 2026-06
- 1.2LetPub ·
- h-index
- 74LetPub ·
- h-index
- 112OpenAlex ·
- i10-index
- 1,154OpenAlex ·
- 2-year mean citedness
- 1.76OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 96LetPub ·
Articles by year OpenAlex count · 5,791 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 94 | 94 | 65 |
| 2025 | 561 | 561 | 462 |
| 2024 | 72 | 72 | 755 |
| 2023 | 74 | 74 | 1,761 |
| 2022 | 62 | 62 | 1,417 |
| 2021 | 54 | 34 | 1,018 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
96 daysMedian, submission to acceptance · P25–P75 71 days – 143 days
- Acceptance to online
- median 3 days (101 articles)
- Submission to online
- median 101 days
- Sample
- 101 articles with submission and acceptance dates (247 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 35%LetPub ·
- Acceptance rate (publisher)
- 34%Publisher website ·
- Submission to first decision
- 1 daysPublisher website ·
- Submission to acceptance
- 139 daysPublisher website ·
- Acceptance to publication
- 5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,180 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,670 / EUR 3,430 / GBP 2,940 / JPY 455,190 | — | — | |
| Publisher website | USD 4,040 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Cover letter
- Required
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Data statement encouraged Model summary
To foster transparency, you are encouraged to state the availability of any data at submission.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of one reviewer for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Rea…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2008
- ISSN
- 1871-6784
- Electronic ISSN
- 1876-4347
- Society / sponsor
- European Federation of Biotechnology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about New Biotechnology
What CAS zone is New Biotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, New Biotechnology is in Zone 2 of Biology, and in Zone 2 of the minor category Biochemical Research Methods / Biotechnology & Applied Microbiology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of New Biotechnology?
The latest impact factor listed by LetPub is 5.65; CiteScore 9.2, h-index 112.
How long does peer review take at New Biotechnology?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 96 days (interquartile range 71–143 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly easy (Elsevier website: 35%)”; the journal's website gives an acceptance rate of 34%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of New Biotechnology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of New Biotechnology based?
Of the 49 board members whose country the journal's board page names, 5 (about 10%) are in mainland China; the countries named most often are United States (15), Germany (6) and Mainland China (5). Counted from the institutions listed on the board page; for reference only.
Which databases index New Biotechnology?
According to LetPub and DOAJ records, New Biotechnology is indexed in SCIE, Scopus and DOAJ.
Is New Biotechnology open access, and what is the APC?
New Biotechnology is a fully open-access journal. APC about USD 3,180.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .